Rezo Therapeutics

About:

Rezo Therapeutics identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence.

Website: https://www.rezotx.com

Top Investors: Eli Lilly, Andreessen Horowitz, Alexandria Venture Investments, Liquid 2 Ventures, Norwest Venture Partners

Description:

Rezo Therapeutics identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence. Rezo's proprietary platform can be used to treat a wide range of diseases. Rezo's initial focus is oncology, with plans to expand into other therapeutic areas through collaborations and partnerships.

Total Funding Amount:

$78M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

2021-01-01

Contact Email:

info(AT)rezotx.com

Founders:

George Scangos, Kevan Shokat, Natalia Jura, Nevan Krogan, Norbert Bischofberger, Sourav Bandyopadhyay

Number of Employees:

1-10

Last Funding Date:

2022-11-17

IPO Status:

Private

© 2024 MyAiNote.com